annual FCF:
-$73.24M-$11.82M(-19.24%)Summary
- As of today (August 22, 2025), ELVN annual free cash flow is -$73.24 million, with the most recent change of -$11.82 million (-19.24%) on December 31, 2024.
- During the last 3 years, ELVN annual FCF has fallen by -$53.91 million (-278.97%).
- ELVN annual FCF is now -734.41% below its all-time high of -$8.78 million, reached on December 1, 2018.
Performance
ELVN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$17.20M+$6.95M(+28.79%)Summary
- As of today (August 22, 2025), ELVN quarterly free cash flow is -$17.20 million, with the most recent change of +$6.95 million (+28.79%) on June 30, 2025.
- Over the past year, ELVN quarterly FCF has increased by +$3.24 million (+15.86%).
- ELVN quarterly FCF is now -166.15% below its all-time high of -$6.46 million, reached on September 30, 2022.
Performance
ELVN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$70.76M+$3.24M(+4.38%)Summary
- As of today (August 22, 2025), ELVN TTM free cash flow is -$70.76 million, with the most recent change of +$3.24 million (+4.38%) on June 30, 2025.
- Over the past year, ELVN TTM FCF has increased by +$1.46 million (+2.03%).
- ELVN TTM FCF is now -641.57% below its all-time high of -$9.54 million, reached on March 1, 2020.
Performance
ELVN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ELVN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.2% | +15.9% | +2.0% |
| 3 y3 years | -279.0% | -131.5% | -71.0% |
| 5 y5 years | -232.6% | -85.6% | -276.3% |
ELVN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -279.0% | at low | -166.2% | +28.8% | -96.9% | +4.4% |
| 5 y | 5-year | -279.0% | at low | -166.2% | +28.8% | -276.3% | +4.4% |
| alltime | all time | -734.4% | at low | -166.2% | +28.8% | -641.6% | +4.4% |
ELVN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$17.20M(-28.8%) | -$70.76M(-4.4%) |
| Mar 2025 | - | -$24.15M(+40.4%) | -$74.00M(+1.0%) |
| Dec 2024 | -$73.24M(+19.2%) | -$17.20M(+40.8%) | -$73.24M(+6.9%) |
| Sep 2024 | - | -$12.21M(-40.2%) | -$68.53M(-5.1%) |
| Jun 2024 | - | -$20.44M(-12.6%) | -$72.22M(+13.0%) |
| Mar 2024 | - | -$23.38M(+87.1%) | -$63.92M(+4.1%) |
| Dec 2023 | -$61.42M(+70.9%) | -$12.50M(-21.5%) | -$61.42M(+1.7%) |
| Sep 2023 | - | -$15.91M(+31.1%) | -$60.41M(+18.5%) |
| Jun 2023 | - | -$12.14M(-41.9%) | -$50.96M(+10.2%) |
| Mar 2023 | - | -$20.88M(+81.7%) | -$46.25M(+28.7%) |
| Dec 2022 | -$35.93M | -$11.49M(+77.8%) | -$35.93M(-2.7%) |
| Sep 2022 | - | -$6.46M(-13.0%) | -$36.93M(-10.7%) |
| Jun 2022 | - | -$7.43M(-29.6%) | -$41.37M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.55M(-15.5%) | -$44.31M(-5.3%) |
| Dec 2021 | -$19.32M(-48.4%) | - | - |
| Dec 2021 | - | -$12.48M(+14.5%) | -$46.78M(+9.9%) |
| Sep 2021 | - | -$10.90M(+5.2%) | -$42.56M(+1.3%) |
| Jun 2021 | - | -$10.37M(-20.5%) | -$42.01M(+2.7%) |
| Mar 2021 | - | -$13.03M(+57.7%) | -$40.91M(+9.3%) |
| Dec 2020 | -$37.42M(+69.9%) | -$8.27M(-20.1%) | -$37.42M(+28.4%) |
| Sep 2020 | - | -$10.35M(+11.7%) | -$29.15M(+55.0%) |
| Jun 2020 | - | -$9.26M(-2.9%) | -$18.80M(+97.1%) |
| Mar 2020 | - | -$9.54M | -$9.54M |
| Dec 2019 | -$22.02M(+150.8%) | - | - |
| Dec 2018 | -$8.78M(-0.1%) | - | - |
| Dec 2017 | -$8.79M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual FCF year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Enliven Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM FCF year-on-year change?
What is Enliven Therapeutics, Inc. annual free cash flow?
The current annual FCF of ELVN is -$73.24M
What is the all time high annual FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual free cash flow is -$8.78M
What is Enliven Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, ELVN annual free cash flow has changed by -$11.82M (-19.24%)
What is Enliven Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of ELVN is -$17.20M
What is the all time high quarterly FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly free cash flow is -$6.46M
What is Enliven Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, ELVN quarterly free cash flow has changed by +$3.24M (+15.86%)
What is Enliven Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of ELVN is -$70.76M
What is the all time high TTM FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM free cash flow is -$9.54M
What is Enliven Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, ELVN TTM free cash flow has changed by +$1.46M (+2.03%)